Compare Archer Aviation Inc (ACHR) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Archer Aviation Inc vs Regeneron Pharmaceuticals Inc — how do they compare? Archer Aviation Inc trades at $6.88 (market cap $5.23B), while Regeneron Pharmaceuticals Inc trades at $794.9 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 15.7× Archer Aviation Inc's market cap, and Regeneron Pharmaceuticals Inc pays a 0.47% dividend while Archer Aviation Inc pays none. Which is the better fit depends on your goals.
| ACHR | REGN | |
|---|---|---|
Market Cap | $5.23B | $82.06B |
Sector | Industrials | Health |
52-Week High | $13.64 | $812.27 |
52-Week Low | $4.44 | $555.51 |
Enterprise Value | $3.79B | $76.77B |
Dividend Yield | — | 0.47% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Archer Aviation Inc
Archer Aviation develops electric vertical takeoff and landing (eVTOL) aircraft for urban air mobility. Its flagship, Midnight aircraft, is designed for air taxi services, aiming to transform urban travel with sustainable aviation.
Read more on ACHR →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
